Basic and clinical research within the Division of Gastroenterology, Hepatology and Nutrition is enhancing the treatment of children with digestive diseases.
In pediatric liver disease, we study the causes and develop new tests and treatments for biliary and inflammatory diseases, genetic abnormalities and metabolic disorders. We also offer clinical trials for children with cholestasis and inflammatory and viral diseases of the liver.
In pediatric intestinal diseases, we study pathogenesis, genetics and novel treatments for inflammatory bowel disease, eosinophilic esophagitis and preventable diarrheal diseases. We also study the patterns and therapies for motility disorders and explore the causes of liver and intestinal failure. Our laboratory studies examine ways to improve cell survival and the use of new treatments to improve bowel function.
For children requiring liver or intestinal transplantation, our scientists are seeking new biomarkers to guide the optimal level of immunosuppression and are developing clinical protocols to improve long-term outcomes and quality of life.
Learn more about our research efforts.